Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 351 | 3538 | 45.9 | 85% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 103 | 24571 | PARA TUBERCULOSIS//MYCOBACTERIUM BOVIS//JOHNES DISEASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BCG | Author keyword | 44 | 19% | 6% | 211 |
| 2 | TUBERCULOSIS | Journal | 42 | 19% | 6% | 196 |
| 3 | LANZHOU TB | Address | 38 | 93% | 0% | 14 |
| 4 | AG85B | Author keyword | 35 | 81% | 1% | 21 |
| 5 | MYCOBACTERIA S | Address | 34 | 35% | 2% | 78 |
| 6 | UNITAT TB EXPT | Address | 33 | 64% | 1% | 32 |
| 7 | TUBERCULOSIS VACCINE | Author keyword | 31 | 82% | 1% | 18 |
| 8 | TB VACCINE | Author keyword | 27 | 92% | 0% | 11 |
| 9 | ESAT6 | Author keyword | 24 | 82% | 0% | 14 |
| 10 | MVA85A | Author keyword | 24 | 91% | 0% | 10 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BCG | 44 | 19% | 6% | 211 | Search BCG | Search BCG |
| 2 | AG85B | 35 | 81% | 1% | 21 | Search AG85B | Search AG85B |
| 3 | TUBERCULOSIS VACCINE | 31 | 82% | 1% | 18 | Search TUBERCULOSIS+VACCINE | Search TUBERCULOSIS+VACCINE |
| 4 | TB VACCINE | 27 | 92% | 0% | 11 | Search TB+VACCINE | Search TB+VACCINE |
| 5 | ESAT6 | 24 | 82% | 0% | 14 | Search ESAT6 | Search ESAT6 |
| 6 | MVA85A | 24 | 91% | 0% | 10 | Search MVA85A | Search MVA85A |
| 7 | TUBERCULOSIS VACCINES | 19 | 80% | 0% | 12 | Search TUBERCULOSIS+VACCINES | Search TUBERCULOSIS+VACCINES |
| 8 | AG85A | 13 | 58% | 0% | 15 | Search AG85A | Search AG85A |
| 9 | ANTIGEN 85A | 11 | 100% | 0% | 6 | Search ANTIGEN+85A | Search ANTIGEN+85A |
| 10 | TB VACCINES | 11 | 100% | 0% | 6 | Search TB+VACCINES | Search TB+VACCINES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXPERIMENTAL AIRBORNE TUBERCULOSIS | 66 | 79% | 1% | 42 |
| 2 | MYCOBACTERIUM BOVIS BCG | 54 | 23% | 6% | 207 |
| 3 | BACILLE CALMETTE GUERIN | 53 | 31% | 4% | 141 |
| 4 | POLYFUNCTIONAL CD4 | 53 | 89% | 1% | 24 |
| 5 | ANTIGEN 85B | 53 | 78% | 1% | 35 |
| 6 | EFFICIENT PROTECTION | 51 | 83% | 1% | 29 |
| 7 | BOVIS BCG VACCINATION | 51 | 66% | 1% | 47 |
| 8 | BOVIS BCG | 45 | 18% | 6% | 223 |
| 9 | PANTOTHENATE AUXOTROPH | 45 | 80% | 1% | 28 |
| 10 | TUBERCULOSIS INFECTION | 44 | 25% | 4% | 152 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TUBERCULOSIS | 42 | 19% | 6% | 196 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Immunology studies in non-human primate models of tuberculosis | 2015 | 4 | 94 | 66% |
| Cell-Mediated Immune Responses in Tuberculosis | 2009 | 351 | 167 | 56% |
| The Immune Response in Tuberculosis | 2013 | 121 | 323 | 42% |
| Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? | 2012 | 97 | 133 | 65% |
| Immunology of tuberculosis | 2001 | 1215 | 191 | 41% |
| T cells and adaptive immunity to Mycobacterium tuberculosis in humans | 2015 | 3 | 196 | 54% |
| Revisiting the role of the granuloma in tuberculosis | 2012 | 121 | 144 | 44% |
| The success and failure of BCG - implications for a novel tuberculosis vaccine | 2005 | 289 | 66 | 73% |
| Tuberculosis: What We Don't Know Can, and Does, Hurt Us | 2010 | 197 | 55 | 55% |
| The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression | 2015 | 2 | 116 | 63% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LANZHOU TB | 38 | 93% | 0.4% | 14 |
| 2 | MYCOBACTERIA S | 34 | 35% | 2.2% | 78 |
| 3 | UNITAT TB EXPT | 33 | 64% | 0.9% | 32 |
| 4 | S AFRICAN TB VACCINE INITIAT | 20 | 46% | 0.9% | 33 |
| 5 | TB IMMUNOL | 18 | 47% | 0.8% | 29 |
| 6 | SOUTH AFRICAN TB VACCINE INITIAT | 12 | 52% | 0.5% | 16 |
| 7 | MYCOBACTERIAL IMMUN PATHOGENESIS | 9 | 34% | 0.6% | 21 |
| 8 | JENNER | 9 | 16% | 1.4% | 50 |
| 9 | SERV TISIONEUMONOL | 8 | 75% | 0.2% | 6 |
| 10 | MYCOBACTERIAL DIS CELLULAR IMMUNOL | 8 | 36% | 0.5% | 17 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000226574 | KUZELL ARTHRIT INFECT DIS//MICROBIOL IMMUNOL INFECT//T CELL MITOGENESIS |
| 2 | 0.0000155601 | DEVR//PE_PGRS//MOL MYCOBACTERIOL UNIT |
| 3 | 0.0000129277 | ANTIGEN 60//38 KDA ANTIGEN//16 KDA ANTIGEN |
| 4 | 0.0000121362 | TUBERCULIN SKIN TEST//INTERFERON GAMMA RELEASE ASSAY//T SPOTTB |
| 5 | 0.0000110379 | HUMAN GENET INFECT DIS//PEDIAT HEMATOL IMMUNOL UNIT//NECKER MED |
| 6 | 0.0000104812 | SKIN RESPIRATION//REFLECTION OXYMETRY//REFLECTION PHOTOMETRY |
| 7 | 0.0000104401 | GRANULYSIN//NK LYSIN//IMMUNOL TRANSPLANTAT BIOL |
| 8 | 0.0000094248 | MYCOBACTERIOPHAGE L1//RECOMBINANT BCG VACCINE//RECOMBINANT BCG |
| 9 | 0.0000085680 | IDIOPATHIC CD4 T LYMPHOCYTOPENIA//IDIOPATHIC CD4 LYMPHOCYTOPENIA//CD4 LYMPHOCYTOPENIA |
| 10 | 0.0000080238 | SLC11A1//NRAMP1//MCGILL STUDY HOST ISTANCE |